Dermapharm Holding SE
DMPHF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $172,005 | $62,368 | $216,297 | $292,977 |
| Dep. & Amort. | $86,785 | $101,772 | $94,909 | $55,159 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | -$18,056 | $9,042 | -$4,138 | -$46,271 |
| Other Non-Cash | -$39,356 | $46,240 | -$18,535 | -$51,497 |
| Operating Cash Flow | $201,378 | $219,422 | $288,533 | $250,368 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$38,237 | -$41,541 | -$39,014 | -$61,203 |
| Net Acquisitions | $0 | -$389,395 | -$69,786 | -$22,511 |
| Inv. Purchases | -$404 | $0 | -$6,068 | -$48,253 |
| Inv. Sales/Matur. | $707 | $7,948 | $10,000 | $61,203 |
| Other Inv. Act. | $8,320 | $7,556 | $5,860 | -$58,583 |
| Investing Cash Flow | -$29,614 | -$415,432 | -$99,008 | -$129,347 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$101,408 | $300,801 | -$71,244 | -$25,909 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | -$47,379 | -$56,532 | -$116,833 | -$47,379 |
| Other Fin. Act. | -$60,382 | -$39,731 | -$11,691 | -$7,691 |
| Financing Cash Flow | -$209,169 | $204,538 | -$199,768 | -$80,979 |
| Forex Effect | -$37 | -$2 | -$152 | $1,071 |
| Net Chg. in Cash | -$37,440 | $7,696 | -$10,395 | $41,114 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $158,715 | $151,019 | $161,414 | $120,300 |
| End Cash | $121,275 | $158,715 | $151,019 | $161,414 |
| Free Cash Flow | $163,141 | $177,881 | $249,519 | $189,165 |